Heron Therapeutics Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heron therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heron Therapeutics Company Profile Today - Breaking & Trending Today

Heron Therapeutics, Inc. (NASDAQ:HRTX) Sees Large Growth in Short Interest

Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily volume of 2,410,000 shares, the short-interest ratio […] ....

Needham Company , Tejara Capital Ltd , Congress Park Capital , Heron Therapeutics Company Profile , Heron Therapeutics Inc , Heron Therapeutics , Get Free Report , One Financial , Capital Management , Asset Management , Spark Capital , Capital Partners , Capital Ltd , Heron Therapeutics Daily ,

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Up 10.9% in May

Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily trading volume, of 2,410,000 […] ....

Heron Therapeutics Inc , Tejara Capital Ltd , Heron Therapeutics Company Profile , Needham Company , Jw Asset Management , Orchard Capital Management , Heron Therapeutics , Get Free Report , One Financial , Capital Management , Asset Management , Capital Ltd , Heron Therapeutics Daily ,

Capital One Financial Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)

Capital One Financial started coverage on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $6.00 price objective on the biotechnology company’s stock. Capital One Financial also issued estimates for Heron Therapeutics’ Q1 2024 earnings at […] ....

Heron Therapeutics Company Profile , Richmond Brothers Inc , Needham Company , Orchard Capital Management , Heron Therapeutics Inc , Panagora Asset Management Inc , Capital One Financial , Heron Therapeutics , Free Report , One Financial , Get Free Report , Capital Management , Asset Management , Monaco Asset Management , Heron Therapeutics Daily , Nasdaq Hrtx , Initiated Coverage , Capital One Financial Co ,

Heron Therapeutics (NASDAQ:HRTX) Earns Overweight Rating from Analysts at Capital One Financial

Heron Therapeutics (NASDAQ:HRTX) Earns Overweight Rating from Analysts at Capital One Financial
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Heron Therapeutics Company Profile , Richmond Brothers Inc , Panagora Asset Management Inc , Heron Therapeutics Inc , Needham Company , Orchard Capital Management , Capital One Financial , Heron Therapeutics , Free Report , One Financial , Get Free Report , Capital Management , Asset Management , Monaco Asset Management , Heron Therapeutics Daily ,